Access begins with Artia.
Artia Solutions launched over 42% of all drugs approved in the U.S. in 2024.
We set the standard in Medicaid access consulting — from drug launch strategy to supplemental rebate bid analysis to product monitoring.
Our Story
After several years in the pharmaceutical industry—and two years as the pharmacy director of Florida Medicaid—George Kitchens, RPh, saw a need for strategic Medicaid access consulting for drug manufacturers. The light bulb went off, and he founded Artia Solutions in 2005. The one-man show quickly grew into a full-fledged national Medicaid consulting firm with over 40 employees. Artia’s team of PharmDs and analysts holds more than 100 years of combined Medicaid policy, administrative, clinical, legislative, and budgeting experience.
Supporting Solutions
Our custom-built technology and curated tools assist our clients in effectively forecasting access upon launch, understanding coverage landscapes, and monitoring their products post-launch.
More on our products
The App
The Artia App, available for iOS and Android, provides Medicaid P&T and DUR meeting information and market share data for every state.
Learn More
Capsule
Capsule is our proprietary database that houses state-specific Medicaid information for pharmaceutical manufacturers.
Learn More
Featured Clients
Our clients range from new drug manufacturers with a specialty drug to drug manufacturers with an established portfolio. Regardless of company size or service level, we're dedicated to the hard work that a successful Medicaid access strategy requires. It’s a journey, and we’re with our clients every step of the way to ensure the most favorable outcome.
New From Our Blog
More
Summary of Provisions in HR 1 Affecting Manufacturers Serving Medicare, Medicaid, CHIP, and the ACA Marketplace
HR 1 (2025) is the most significant law affecting Medicare, Medicaid, CHIP, and the ACA marketplace in over a decade. This Summary of the new law, and potential direct and indirect effects on the industry are provided for each provision contained in the law. The Summary also provides an initial assessment on how states will react to the far-ranging policy provisions.
Read More
The Year in Medicaid 2024
In this look back at the events of 2024, we recap significant events that shaped Medicaid pharmacy practice.
Read More
What the Medicaid Rebate Final Rule Means for Manufacturers
On November 19, 2024, the 2024 Medicaid Rebate Final Rule went into effect. The Final Rule establishes new oversight and enforcement measures for the Medicaid Drug Rebate Program (MDRP), primarily based on the changes introduced by the Medicaid Services Investment and Accountability Act of 2019 (MSIAA).
Read More